Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Hadassah Medical Center - Gene Therapy: Galun Eithan


Last updated December 2021 - Gene Therapy

List of Publications

(1) Levite M, Safadi R, Milgrom Y, Massarwa M, Galun E. Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells. Neuropeptides 2021;89.

(2) Shriki A, Lanton T, Sonnenblick A, Levkovitch-Siany O, Eidelshtein D, Abramovitch R, et al. Multiple roles of il6 in hepatic injury, steatosis, and senescence aggregate to suppress tumorigenesis. Cancer Res 2021;81(18):4766-4777.

(3) Schmidt-Arras D, Galun E, Rose-John S. The two facets of gp130 signalling in liver tumorigenesis. Semin Immunopathol 2021;43(4):609-624.

(4) Sadeh R, Sharkia I, Fialkoff G, Rahat A, Gutin J, Chappleboim A, et al. Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin (Nature Biotechnology, (2021), 39, 5, (586-598), 10.1038/s41587-020-00775-6). Nat Biotechnol 2021;39(5):642.

(5) Sadeh R, Sharkia I, Fialkoff G, Rahat A, Gutin J, Chappleboim A, et al. ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin. Nat Biotechnol 2021;39(5):586-598.

(6) Chai C, Giladi H, Galun E. Reply. Gastroenterology 2021;160(5):1882-1883.

(7) Harari-Steinfeld R, Gefen M, Simerzin A, Zorde-Khvalevsky E, Rivkin M, Ella E, et al. The lncrna h19-derived microrna-675 promotes liver necroptosis by targeting fadd. Cancers 2021;13(3):1-17.

(8) Gamaev L, Mizrahi L, Friehmann T, Rosenberg N, Pappo O, Olam D, et al. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma. Oncogene 2021;40(1):127-139.

(9) Markezana A, Goldberg SN, Kumar G, Zorde-Khvalevsky E, Gourevtich S, Rozenblum N, et al. Incomplete thermal ablation of tumors promotes increased tumorigenesis. Int J Hyperthermia 2021;38(1):263-272.

(10) Chai C, Cox B, Yaish D, Gross D, Rosenberg N, Amblard F, et al. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122. Gastroenterology 2020;159(3):999-1014.e9.

(11) Levite M, Zelig D, Friedman A, Ilouz N, Eilam R, Bromberg Z, et al. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells. J Autoimmun 2020;112.

(12) Benedek G, El Latif MA, Miller K, Rivkin M, Lasu AAR, Riek LP, et al. Protection or susceptibility to devastating childhood epilepsy: Nodding syndrome associates with immunogenetic fingerprints in the hla binding groove. PLoS Negl Trop Dis 2020;14(7):1-15.

(13) Guedj A, Volman Y, Geiger-Maor A, Bolik J, Schumacher N, Künzel S, et al. Gut microbiota shape 'inflamm-ageing' cytokines and account for age-dependent decline in DNA damage repair. Gut 2020;69(6):1064-1075.

(14) Liao H, Ahmed M, Markezana A, Zeng G, Stechele M, Galun E, et al. Thermal ablation induces transitory metastatic growth by means of the STAT3/c-Met molecular pathway in an intrahepatic colorectal cancer mouse model. Radiology 2020;294(2):464-472.

(15) Markezana A, Ahmed M, Kumar G, Zorde-Khvalevsky E, Rozenblum N, Galun E, et al. Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activity. Int J Hyperthermia 2020;37(1):119-129.

(16) Birger A, Ben-Dor I, Ottolenghi M, Turetsky T, Gil Y, Sweetat S, et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine 2019;50:274-289.

(17) Benedek G, Abed El-Latif M, Miller K, Galun E, Levite M. Identification of the novel HLA-B allele, HLA-B*15:539, in a South-Sudanese individual. HLA 2019;94(4):380-381.

(18) Potikha T, Pappo O, Mizrahi L, Olam D, Maller SM, Rabinovich GA, et al. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model. FASEB J 2019;33(7):7995-8007.

(19) Gozlan Y, Bucris E, Shirazi R, Rakovsky A, Ben-Ari Z, Davidov Y, et al. High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: Real-life data. Antiviral Ther 2019;24(3):221-228.

(20) Ahmed M, Kumar G, Gourevitch S, Levchenko T, Galun E, Torchilin V, et al. Radiofrequency ablation (RFA)-induced systemic tumor growth can be reduced by suppression of resultant heat shock proteins. Int J Hyperthermia 2018;34(7):934-942.

(21) Werlin S, Scotet V, Uguen K, Audrezet M-, Cohen M, Yaakov Y, et al. Primary sclerosing cholangitis is associated with abnormalities in CFTR. J Cyst Fibrosis 2018;17(5):666-671.

(22) Chai C, Galun E, Giladi H. Reply. Gastroenterology 2018;154(5):1553-1554.

(23) Klein S, Abraham M, Bulvik B, Dery E, Weiss ID, Barashi N, et al. CXCR4 promotes neuroblastoma growth and therapeutic resistance through miR-15a/ 16-1–mediated ERK and BCL2/Cyclin D1 pathways. Cancer Res 2018;78(6):1471-1483.

(24) Kumar G, Goldberg SN, Gourevitch S, Levchenko T, Torchilin V, Galun E, et al. Targeting STAT3 to suppress systemic pro-oncogenic effects from hepatic radiofrequency ablation. Radiology 2018;286(2):524-536.

(25) Moll JM, Wehmöller M, Frank NC, Homey L, Baran P, Garbers C, et al. Split2 Protein-Ligation Generates Active IL-6-Type Hyper-Cytokines from Inactive Precursors. ACS Synth Biol 2017;6(12):2260-2272.

(26) Kleinschmidt D, Giannou AD, McGee HM, Kempski J, Steglich B, Huber FJ, et al. A protective function of IL-22BP in ischemia reperfusion and acetaminophen-induced liver injury. J Immunol 2017;199(12):4078-4090.

(27) Abraham M, Wald H, Vaizel-Ohayon D, Grabovsky V, Oren Z, Karni A, et al. Development of novel promiscuous anti-chemokine peptibodies for treating autoimmunity and inflammation. Front Immunol 2017;8(NOV).

(28) Abraham M, Pereg Y, Bulvik B, Klein S, Mishalian I, Wald H, et al. Single dose of the CXCR4 antagonist BL-8040 induces rapid mobilization for the collection of human CD34 + cells in healthy volunteers. Clin Cancer Res 2017;23(22):6790-6801.

(29) Chai C, Rivkin M, Berkovits L, Simerzin A, Zorde-Khvalevsky E, Rosenberg N, et al. Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues. Gastroenterology 2017;153(5):1404-1415.

(30) Abraham M, Klein S, Bulvik B, Wald H, Weiss ID, Olam D, et al. The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression. Leukemia 2017;31(11):2336-2346.

(31) Guedj A, Geiger-Maor A, Benyamini H, Nevo Y, Elgavish S, Galun E, et al. Correction: Early age decline in DNA repair capacity in the liver: In depth profile of differential gene expression [Aging (Albany NY), 8, 11, (2017) (3131-3141)] DOI: 10.18632/aging.101120. Aging 2017;9(6):1640.

(32) Avraham Y, Hants Y, Vorobeiv L, Staum M, Abu Ahmad W, Mankuta D, et al. Brain neurotransmitters in an animal model with postpartum depressive-like behavior. Behav Brain Res 2017;326:307-321.

(33) Lanton T, Shriki A, Nechemia-Arbely Y, Abramovitch R, Levkovitch O, Adar R, et al. Interleukin 6–dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis. Hepatology 2017;65(5):1600-1611.

(34) Beider K, Rosenberg E, Bitner H, Shimoni A, Leiba M, Koren-Michowitz M, et al. The sphingosine-1-phosphate modulator FTY720 targets multiple myeloma via the CXCR4/CXCL12 pathway. Clin Cancer Res 2017;23(7):1733-1747.

(35) Kumar G, Goldberg SN, Wang Y, Velez E, Gourevitch S, Galun E, et al. Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition. Eur Radiol 2017;27(3):1238-1247.

(36) Stoyanov E, Mizrahi L, Olam D, Schnitzer-Perlman T, Galun E, Goldenberg DS. Tumor-suppressive effect of S-adenosylmethionine supplementation in a murine model of inflammation-mediated hepatocarcinogenesis is dependent on treatment longevity. Oncotarget 2017;8(62):104772-104784.

(37) Rivkin M, Simerzin A, Zorde-Khvalevsky E, Chai C, Yuval JB, Rosenberg N, et al. Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and Anemia. Gastroenterology 2016;151(5):999-1010.e3.

(38) Simerzin A, Zorde-Khvalevsky E, Rivkin M, Adar R, Zucman-Rossi J, Couchy G, et al. The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry. Hepatology 2016;64(5):1623-1636.

(39) Bulvik BE, Rozenblum N, Gourevich S, Ahmed M, Andriyanov AV, Galun E, et al. Irreversible electroporation versus radiofrequency ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model1. Radiology 2016;280(2):413-424.

(40) Potikha T, Ella E, Cerliani JP, Mizrahi L, Pappo O, Rabinovich GA, et al. Galectin-1 is essential for efficient liver regeneration following hepatectomy. Oncotarget 2016;7(22):31738-31754.

(41) Chapiro J, Goldberg SN, Galun E, Geschwind J-. Response. Radiology 2016;279(1):323.

(42) Ahmed M, Kumar G, Moussa M, Wang Y, Rozenblum N, Galun E, et al. Hepatic radiofrequency ablation-induced stimulation of distant tumor growth is suppressed by c-Met inhibition. Radiology 2016;279(1):103-117.

(43) Marmary Y, Adar R, Gaska S, Wygoda A, Maly A, Cohen J, et al. Radiation-induced loss of salivary gland function is driven by cellular senescence and prevented by IL6 modulation. Cancer Res 2016;76(5):1170-1180.

(44) Galun E. Liver inflammation and cancer: The role of tissue microenvironment in generating the tumor-promoting niche (TPN) in the development of hepatocellular carcinoma. Hepatology 2016;63(2):354-356.

(45) Guedj A, Geiger-Maor A, Galun E, Amsalem H, Rachmilewitz J. Early age decline in DNA repair capacity in the liver: In depth profile of differential gene expression. Aging 2016;8(11):3131-3146.

(46) Zahavi T, Lanton T, Divon MS, Salmon A, Peretz T, Galun E, et al. Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model. Oncotarget 2016;7(4):4860-4870.

(47) Hen G, Yosefi S, Shinder D, Or A, Mygdal S, Condiotti R, et al. Erratum: Gene transfer to chicks using lentiviral vectors administered via the embryonic chorioallantoic membrane (PLoS ONE (2012) 7:5 (e36531) DOI:10.1371/journal.pone.0036531). PLoS ONE 2015;10(9).

(48) Rozenblum N, Zeira E, Bulvik B, Gourevitch S, Yotvat H, Galun E, et al. Radiofrequency ablation: Inflammatory changes in the periablative zone can induce global organ effects, including liver regeneration. Radiology 2015;276(2):416-425.

(49) Rozenblum N, Zeira E, Scaiewicz V, Bulvik B, Gourevitch S, Yotvat H, et al. Oncogenesis: An "off-target" effect of radiofrequency ablation. Radiology 2015;276(2):426-432.

(50) Ahmed M, Kumar G, Navarro G, Wang Y, Gourevitch S, Moussa MH, et al. Systemic siRNA nanoparticle-based drugs combined with radiofrequency ablation for cancer therapy. PLoS ONE 2015;10(7).

(51) Geiger-Maor A, Guedj A, Even-Ram S, Smith Y, Galun E, Rachmilewitz J. Macrophages regulate the systemic response to DNA damage by a cell nonautonomous mechanism. Cancer Res 2015;75(13):2663-2673.

(52) Zeira E, Abramovitch R, Meir K, Ram SE, Gil Y, Bulvik B, et al. The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells. Oncotarget 2015;6(33):34691-34703.

(53) Golan T, Khvalevsky EZ, Hubert A, Gabai RM, Hen N, Segal A, et al. RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients. Oncotarget 2015;6(27):24560-24570.

(54) Stoyanov E, Ludwig G, Mizrahi L, Olam D, Schnitzer-Perlman T, Tasika E, et al. Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis. Oncotarget 2015;6(13):11047-11060.

(55) Peled A, Abraham M, Avivi I, Rowe JM, Beider K, Wald H, et al. The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myeloma. Clin Cancer Res 2014;20(2):469-479.

(56) Beider K, Bitner H, Leiba M, Gutwein O, Koren-Michowitz M, Ostrovsky O, et al. Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype. Oncotarget 2014;5(22):11283-11296.

(57) Ella E, Heim D, Stoyanov E, Harari-Steinfeld R, Steinfeld I, Pappo O, et al. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver. Oncotarget 2014;5(21):10318-10331.

(58) Beider K, Darash-Yahana M, Blaier O, Koren-Michowitz M, Abraham M, Wald H, et al. Combination of imatinib with CXCR4 Antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo. Mol Cancer Ther 2014;13(5):1155-1169.

(59) Nachmani D, Zimmermann A, Oiknine Djian E, Weisblum Y, Livneh Y, Khanh Le VT, et al. MicroRNA Editing Facilitates Immune Elimination of HCMV Infected Cells. PLoS Pathog 2014;10(2).

(60) Condiotti R, Goldenberg D, Giladi H, Schnitzer-Perlman T, Waddington SN, Buckley SM, et al. Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature. Mol Ther 2014;22(1):59-68.

(61) Khvalevsky EZ, Gabai R, Rachmut IH, Horwitz E, Brunschwig Z, Orbach A, et al. Mutant KRAS is a druggable target for pancreatic cancer. Proc Natl Acad Sci U S A 2013;110(51):20723-20728.

(62) Abu-Tair L, Axelrod JH, Doron S, Ovadya Y, Krizhanovsky V, Galun E, et al. Natural killer cell-dependent anti-fibrotic pathway in liver injury via toll-like receptor-9. PLoS ONE 2013;8(12).

(63) Barashi N, Weiss ID, Wald O, Wald H, Beider K, Abraham M, et al. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice. Hepatology 2013;58(3):1021-1030.

(64) Beider K, Ribakovsky E, Abraham M, Wald H, Weiss L, Rosenberg E, et al. Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140. Clin Cancer Res 2013;19(13):3495-3507.

(65) Potikha T, Stoyanov E, Pappo O, Frolov A, Mizrahi L, Olam D, et al. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis. Hepatology 2013;58(1):192-204.

(66) Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirsch J, et al. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest 2013;123(6):2703-2718.

(67) Sonnenblick A, Uziely B, Nechushtan H, Kadouri L, Galun E, Axelrod JH, et al. Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 2013;138(2):407-413.

(68) Galun E, Rose-John S. The regenerative activity of interleukin-6. Methods Mol Biol 2013;982:59-77.

(69) Nechemia-Arbely Y, Khamaisi M, Rosenberger C, Koesters R, Shina A, Geva C, et al. In vivo evidence suggesting reciprocal renal hypoxia-inducible factor-1 upregulation and signal transducer and activator of transcription 3 activation in response to hypoxic and non-hypoxic stimuli. Clin Exp Pharmacol Physiol 2013;40(4):262-272.

(70) Manevitch Z, Lewis A, Levy C, Zeira E, Banin E, Manevitch A, et al. Subsurface femtosecond tissue alteration: Selectively photobleaching macular degeneration pigments in near retinal contact. J Phys Chem B 2012;116(23):6945-6951.

(71) Hen G, Yosefi S, Shinder D, Or A, Mygdal S, Condiotti R, et al. Gene transfer to chicks using lentiviral vectors administered via the embryonic chorioallantoic membrane. PLoS ONE 2012;7(5).

(72) Sonnenblick A, Shriki A, Galun E, Axelrod JH, Daum H, Rottenberg Y, et al. Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis. Clin Transl Oncol 2012;14(3):232-236.

(73) Skorecki K, Galun E. Cell and Gene Therapy. Goldman's Cecil Medicine: Twenty Fourth Edition; 2012. p. 203-211.

(74) Globerman AS, Chaouat M, Shlomai Z, Galun E, Zeira E, Zamir G. Efficient transgene expression from naked DNA delivered into an arterio-venous fistula model for kidney dialysis. J Gene Med 2011;13(11):611-621.

(75) Weiss ID, Shoham H, Wald O, Wald H, Beider K, Abraham M, et al. Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions. Cytokine 2011;54(3):249-257.

(76) Nechemia-Arbely Y, Shriki A, Denz U, Drucker C, Scheller J, Raub J, et al. Early hepatocyte DNA synthetic response posthepatectomy is modulated by IL-6 trans-signaling and PI3K/AKT activation. J Hepatol 2011;54(5):922-929.

(77) Beider K, Begin M, Abraham M, Wald H, Weiss ID, Wald O, et al. CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. Exp Hematol 2011;39(3):282-292.

(78) Edrei Y, Gross E, Corchia N, Tsarfaty G, Galun E, Pappo O, et al. Vascular profile characterization of liver tumors by magnetic resonance imaging using hemodynamic response imaging in mice. Neoplasia 2011;13(3):244-253.

(79) Cohen-Haguenauer O, Creff N, Cruz P, Tunc C, Aïuti A, Baum C, et al. Relevance of an Academic GMP Pan-European Vector Infra-Structure (PEVI). Curr Gene Ther 2010;10(6):414-422.

(80) Weiss ID, Wald O, Wald H, Beider K, Abraham M, Galun E, et al. IFN-γ treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. J Interferon Cytokine Res 2010;30(6):439-449.

(81) Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-lail R, Fellig Y, et al. The oncofetal H19 RNA connection: Hypoxia, p53 and cancer. Biochim Biophys Acta Mol Cell Res 2010;1803(4):443-451.

(82) Barash H, Gross ER, Edrei Y, Ella E, Israel A, Cohen I, et al. Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc Natl Acad Sci U S A 2010;107(5):2207-2212.

(83) Grinshpun A, Condiotti R, Waddington SN, Peer M, Zeig E, Peretz S, et al. Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector. Mol Ther 2010;18(9):1592-1598.

(84) Rudich N, Zamir G, Pappo O, Shlomai Z, Faroja M, Weiss ID, et al. Focal liver necrosis appears early after partial hepatectomy and is dependent on T cells and antigen delivery from the gut. Liver Int 2009;29(8):1273-1284.

(85) Zorde-Khvalevsky E, Abramovitch R, Barash H, Spivak-Pohis I, Rivkin L, Rachmilewitz J, et al. Toll-like receptor 3 signaling attenuates liver regeneration. Hepatology 2009;50(1):198-206.

(86) Tzur G, Israel A, Levy A, Benjamin H, Meiri E, Shufaro Y, et al. Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development. PLoS ONE 2009;4(10).

(87) Israel A, Sharan R, Ruppin E, Galun E. Increased MicroRNA activity in human cancers. PLoS ONE 2009;4(6).

(88) Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol 2009;21(6):688-692.

(89) Ram SE, Galun E. AAV2-GDNF gene therapy for Parkinson's disease. Hum Gene Ther 2009;20(5):430-431.

(90) Klopstock N, Katzenellenbogen M, Pappo O, Sklair-Levy M, Olam D, Mizrahi L, et al. HCV tumor promoting effect is dependent on host genetic background. PLoS ONE 2009;4(4).

(91) Beider K, Abraham M, Begin M, Wald H, Weiss ID, Wald O, et al. Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS ONE 2009;4(4).

(92) Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, et al. A plant-derived recombinant human glucocerebrosidase enzyme - A preclinical and phase I investigation. PLoS ONE 2009;4(3).

(93) Abraham M, Beider K, Wald H, Weiss ID, Zipori D, Galun E, et al. The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation. Leukemia 2009;23(8):1378-1388.

(94) Tzur G, Levy A, Meiri E, Barad O, Spector Y, Bentwich Z, et al. MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells. PLoS ONE 2008;3(11).

(95) Barash H, Gross E, Edrei Y, Pappo O, Spira G, Vlodavsky I, et al. Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia. Hepatology 2008;48(4):1232-1241.

(96) Nechemia-Arbely Y, Barkan D, Pizov G, Shriki A, Rose-John S, Galun E, et al. IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol 2008;19(6):1106-1115.

(97) Ben Moshe T, Kang T-, Kovalenko A, Barash H, Abramovitch R, Galun E, et al. Cell-autonomous and non-cell-autonomous functions of caspase-8. Cytokine Growth Factor Rev 2008;19(3-4):209-217.

(98) Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, et al. Molecular mechanisms of liver carcinogenesis in the Mdr2-knockout mice. Mol Cancer Res 2007;5(11):1159-1170.

(99) Zeira E, Manevitch A, Manevitch Z, Kedar E, Gropp M, Daudi N, et al. Femtosecond laser: A new intradermal DNA delivery method for efficient, long-term gene expression and genetic immunization. FASEB J 2007;21(13):3522-3533.

(100) Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-Lail R, Hochberg A, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007;2(9).

(101) Abraham M, Biyder K, Begin M, Wald H, Weiss ID, Galun E, et al. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4f-benzoyl-TN14003. Stem Cells 2007;25(9):2158-2166.

(102) Klopstock N, Levy C, Olam D, Galun E, Goldenberg D. Testing transgenic regulatory elements through live mouse imaging. FEBS Lett 2007;581(21):3986-3990.

(103) Wald O, Weiss ID, Galun E, Peled A. Chemokines in hepatitis C virus infection: Pathogenesis, prognosis and therapeutics. Cytokine 2007;39(1):50-62.

(104) Barash H, Gross E, Matot I, Edrei Y, Tsarfaty G, Spira G, et al. Functional MR imaging during hypercapnia and hyperoxia: Noninvasive tool for monitoring changes in liver perfusion and hemodynamics in a rat model. Radiology 2007;243(3):727-735.

(105) Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Barash H, et al. Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice. Mol Cancer Ther 2007;6(4):1283-1291.

(106) Ben Moshe T, Barash H, Kang T-, Kim J-, Kovalenko A, Gross E, et al. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 2007;45(4):1014-1024.

(107) Khvalevsky E, Rivkin L, Rachmilewitz J, Galun E, Giladi H. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem 2007;100(5):1301-1312.

(108) Zamir G, Zeira E, Gelman AE, Shaked A, Olthoff KM, Eid A, et al. Replication-deficient adenovirus induces aost topoisomerase I activity: Implications for adenovirus-mediated gene expression. Mol Ther 2007;15(4):772-781.

(109) Rivo J, Zeira E, Galun E, Einav S, Linden J, Matot I. Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock 2007;27(3):266-273.

(110) Galun E, Terrault NA, Eren R, Zauberman A, Nussbaum O, Terkieltaub D, et al. Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activity. J Hepatol 2007;46(1):37-44.

(111) Wald O, Izhar U, Amir G, Avniel S, Bar-Shavit Y, Wald H, et al. CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma. J Immunol 2006;177(10):6983-6990.

(112) Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Tur-Kaspa R, et al. Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study. Liver Transplant 2006;12(9):1381-1389.

(113) Ketzinel-Gilad M, Shaul Y, Galun E. RNA interference for antiviral therapy. J Gene Med 2006;8(8):933-950.

(114) Ben-Dor I, Itsykson P, Goldenberg D, Galun E, Reubinoff BE. Lentiviral Vectors Harboring a Dual-Gene System Allow High and Homogeneous Transgene Expression in Selected Polyclonal Human Embryonic Stem Cells. Mol Ther 2006;14(2):255-267.

(115) Mitchell LA, Joseph A, Kedar E, Barenholz Y, Galun E. Mucosal immunization against hepatitis A: Antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid. Vaccine 2006;24(25):5300-5310.

(116) Dagan-Berger M, Feniger-Barish R, Avniel S, Wald H, Galun E, Grabovsky V, et al. Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11. Blood 2006;107(10):3821-3831.

(117) Matot I, Weiniger CF, Zeira E, Galun E, Joshi BV, Jacobson KA. A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion. Crit Care 2006;10(2).

(118) Katzenellenbogen M, Pappo O, Barash H, Klopstock N, Mizrahi L, Olam D, et al. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice. Cancer Res 2006;66(8):4001-4010.

(119) Wald O, Weiss ID, Wald H, Shoham H, Bar-Shavit Y, Beider K, et al. IFN-γ acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 2006;176(8):4716-4729.

(120) Ketzinel-Gilad M, Zauberman A, Nussbaum O, Shoshany Y, Ben-Moshe O, Pappo O, et al. The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapy. Hepatol Res 2006;34(4):228-237.

(121) Eren R, Landstein D, Terkieltaub D, Nussbaum O, Zauberman A, Ben-Porath J, et al. Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): A potential treatment to prevent HCV reinfection in liver transplant patients. J Virol 2006;80(6):2654-2664.

(122) Avniel S, Arik Z, Maly A, Sagie A, Basst HB, Yahana MD, et al. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 2006;126(2):468-476.

(123) Freeman AI, Zakay-Rones Z, Gomori JM, Linetsky E, Rasooly L, Greenbaum E, et al. Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther 2006;13(1):221-228.

(124) Shai E, Palmon A, Panet A, Marmary Y, Sherman Y, Curran MA, et al. Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transduction. Mol Ther 2005;12(1):137-143.

(125) Arad U, Zeira E, El-Latif MA, Mukherjee S, Mitchell L, Pappo O, et al. Liver-targeted gene therapy by SV40-based vectors using the hydrodynamic injection method. Hum Gene Ther 2005;16(3):361-371.

(126) Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005;105(5):2214-2219.

(127) Lippin Y, Dranitzki-Elhalel M, Brill-Almon E, Mei-Zahav C, Mizrachi S, Liberman Y, et al. Human erythropoietin gene therapy for patients with chronic renal failure. Blood 2005;106(7):2280-2286.

(128) Grez M, Galun E, Moullier P. The twelfth annual meeting of the European Society of Gene Therapy. Mol Ther 2005;11(2):178-179.

(129) Wald O, Pappo O, Ari ZB, Azzaria E, Wiess ID, Gafnovitch I, et al. The CCR5Δ32 allele is associated with reduced liver inflammation in hepatitis C virus infection. Eur J Immunogenet 2004;31(6):249-252.

(130) Rivo J, Zeira E, Galun E, Matot I. Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis. Am J Transplant 2004;4(12):1941-1948.

(131) Rivo J, Zeira E, Galun E, Matot I. Activation of A 3 adenosine receptors attenuates lung injury after in vivo reperfusion. Anesthesiology 2004;101(5):1153-1159.

(132) Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431(7007):461-466.

(133) Fellig Y, Almogy G, Galun E, Ketzinel-Gilad M. A hepatocellular carcinoma cell line producing mature hepatitis B viral particles. Biochem Biophys Res Commun 2004;321(2):269-274.

(134) Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, et al. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 2004;18(11):1240-1242.

(135) Condiotti R, Curran MA, Nolan GP, Giladi H, Ketzinel-Gilad M, Gross E, et al. Prolonged liver-specific transgene expression by a non-primate lentiviral vector. Biochem Biophys Res Commun 2004;320(3):998-1006.

(136) Matouk I, Ayesh B, Schneider T, Ayesh S, Ohana P, De-Groot N, et al. Oncofetal splice-pattern of the human H19 gene. Biochem Biophys Res Commun 2004;318(4):916-919.

(137) Franitza S, Grabovsky V, Wald O, Weiss I, Beider K, Dagan M, et al. Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells. Eur J Immunol 2004;34(5):1333-1341.

(138) Wald O, Pappo O, Safadi R, Dagan-Berger M, Beider K, Wald H, et al. Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol 2004;34(4):1164-1174.

(139) Abramovitch R, Tavor E, Jacob-Hirsch J, Zeira E, Amariglio N, Pappo O, et al. A Pivotal Role of Cyclic AMP-Responsive Element Binding Protein in Tumor Progression. Cancer Res 2004;64(4):1338-1346.

(140) Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, et al. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 2004;9(4):587-595.

(141) Arad U, Axelrod J, Ben-nun-Shaul O, Oppenheim A, Galun E. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors. J Hepatol 2004;40(3):520-526.

(142) Beider K, Nagler A, Wald O, Franitza S, Dagan-Berger M, Wald H, et al. Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood 2003;102(6):1951-1958.

(143) Zeira E, Manevitch A, Khatchatouriants A, Pappo O, Hyam E, Darash-Yahana M, et al. Femtosecond infrared laser - An efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther 2003;8(2):342-350.

(144) Mitchell LA, Galun E. Rectal immunization of mice with hepatitis A vaccine induces stronger systemic and local immune responses than parenteral immunization. Vaccine 2003;21(13-14):1527-1538.

(145) Bar I, Zilberman Y, Zeira E, Galun E, Honigman A, Turgeman G, et al. Molecular imaging of the skeleton: Quantitative real-time bioluminescence monitoring gene expression in bone repair and development. J Bone Miner Res 2003;18(3):570-578.

(146) Gropp M, Itsykson P, Singer O, Ben-Hur T, Reinhartz E, Galun E, et al. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 2003;7(2):281-287.

(147) Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 2003;8(5):769-776.

(148) Gänsbacher B, Danos O, Dickson G, Thielemans K, Cosset F-, Deglon N, et al. French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT). J Gene Med 2003;5(1):82-84.

(149) Galun E, Axelrod JH. The role of cytokines in liver failure and regeneration: Potential new molecular therapies. Biochim Biophys Acta Mol Cell Res 2002;1592(3):345-358.

(150) Goldenberg D, Ayesh S, Schneider T, Pappo O, Jurim O, Eid A, et al. Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays. Mol Carcinog 2002;33(2):113-124.

(151) Ilan E, Arazi J, Nussbaum O, Zauberman A, Eren R, Lubin I, et al. The hepatitis C virus (HCV)-Trimera mouse: A model for evaluation of agents against HCV. J Infect Dis 2002;185(2):153-161.

(152) Galun E, Eren R, Safadi R, Ashour Y, Terrault N, Keeffe EB, et al. Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties. Hepatology 2002;35(3):673-679.

(153) Safadi R, Galun E, Ashur Y, Eid A, Melhem A, Jurim O, et al. Bone mineral density after liver transplantation. Transplant Proc 2001;33(6):2950.

(154) Shibolet O, Galun E, Bishara A, Eid A, Birmanns B, Ilan Y, et al. Major neurological complications following liver transplantation. Transplant Proc 2001;33(6):2959.

(155) Israeli E, Galun E, Eid A, Ilan Y, Ashur Y, Jurim O, et al. Combination therapy for hepatitis C virus reinfection after orthoptic liver transplantation. Transplant Proc 2001;33(6):2929.

(156) Kolker O, Galun E, Melhem A, Ilan Y, Eid A, Jurim O, et al. Primary biliary cirrhosis and liver transplantation. Transplant Proc 2001;33(6):2932.

(157) Safadi R, Or R, Ilan Y, Naparstek E, Nagler A, Klein A, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant 2001;27(2):183-190.

(158) Sermoneta-Gertel S, Donchin M, Adler R, Baras M, Perlstein T, Manny N, et al. Hepatitis C virus infection in employees of a large university hospital in Israel. Infect Control Hosp Epidemiol 2001;22(12):754-761.

(159) Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod JH. Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol Ther 2001;3(5):683-687.

(160) Honigman A, Zeira E, Ohana P, Abramovitz R, Tavor E, Bar I, et al. Imaging transgene expression in live animals. Mol Ther 2001;4(3):239-249.

(161) Safadi R, Ergunay K, Ilan Y, Klein A, Shouval D, Manny N, et al. TT virus infection in Israeli patients with fulminant hepatic failure. Vox Sang 2000;79(4):242-245.

(162) Galun E, Nahor O, Eid A, Jurim O, Rose-John S, Blum HE, et al. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. Virology 2000;270(2):299-309.

(163) Lavon I, Goldberg I, Amit S, Landsman L, Jung S, Tsuberi B-, et al. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation. Nat Med 2000;6(5):573-577.

(164) Israeli E, Eid A, Nan Y, Adler R, Galun E, Ashur Y, et al. The course of hepatitis B virus after liver transplantation. Transplant Proc 2000;32(4):711.

(165) Haviv YS, Sharkia M, Galun E, Safadi R. Pancreatitis following hepatitis A vaccination. Eur J Med Res 2000;5(5):229-230.

(166) Ketzinel-Gilad M, Colodner SL, Hadary R, Granot E, Shouval D, Galun E. Transient transmission of hepatitis C virus from mothers to newborns. Eur J Clin Microbiol Infect Dis 2000;19(4):267-274.

(167) Böcher WO, Galun E, Marcus H, Daudi N, Terkieltaub D, Shouval D, et al. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. Hepatology 2000;31(2):480-487.

(168) Eren R, Ilan E, Nussbaum O, Lubin I, Terkieltaub D, Arazi Y, et al. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Hepatology 2000;32(3):588-596.

(169) Galun E, Zeira E, Pappo O, Peters M, Rose-John S. Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J 2000;14(13):1979-1987.

(170) Schwartz E, Jenks NP, Van Damme P, Galun E. Hepatitis E virus infection in travelers. Clin Infect Dis 1999;29(5):1312-1314.

(171) Safadi R, Ilan Y, Galun E, Ashur Y, Goldin E, Papo O, et al. Primary sclerosing cholangitis and liver transplantation. Transplant Proc 1999;31(4):1896.

(172) Safadi R, Ilan Y, Jurim O, Schenker J, Galun E, Ashur Y, et al. Pregnancy and liver transplantation. Transplant Proc 1999;31(4):1899-1900.

(173) Safadi R, Ilan Y, Eid A, Galun E, Ashur Y, Goldin E, et al. Solid tumors after liver transplantation. Transplant Proc 1999;31(4):1894-1895.

(174) Böcher WO, Marcus H, Shakarchy R, Dekel B, Shouval D, Galun E, et al. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo. Immunology 1999;96(4):634-641.

(175) Ilan E, Burakova T, Dagan S, Nussaum O, Lubin I, Eren R, et al. The hepatitis B virus-trimera mouse: A model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 1999;29(2):553-562.

(176) Eid A, Simha M, Galun E, Shafrir E, Ziv E, Bar-On H. Effect of donor feeding and fructose reperfusion on warm ischemic injury of rat livers. Transplant Proc 1998;30(3):767-768.

(177) Eid A, Zamir G, Yaron I, Galun E, Safadi R, Schaaps T, et al. Liver transplantation across the ABO barrier: The role of plasmapheresis. Transplant Proc 1998;30(3):701-703.

(178) Eren R, Lubin I, Terkieltaub D, Ben-Moshe O, Zauberman A, Uhlmann R, et al. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: The Trimera system. Immunology 1998;93(2):154-161.

(179) Safadi R, Shouval D, Ashur Y, Eid A, Jurim O, Livni N, et al. Natural course of HCV viremia following liver transplantation and clinical course of reinfection. Transplant Proc 1997;29(6):2635-2639.

(180) Rojansky N, Shushan A, Livni N, Jurim O, Sulam M, Galun E. Pregnancy associated with colon carcinoma overexpressing p53. Gynecol Oncol 1997;64(3):516-520.

(181) Klein A, Barsuk R, Dagan S, Nusbaum O, Shouval D, Galun E. Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences. J Clin Microbiol 1997;35(7):1897-1899.

(182) Zelingher J, Putterman C, Ilan Y, Dann EJ, Zveibil F, Shvil Y, et al. Case series: Hyponatremia associated with moderate exercise. Am J Med Sci 1996;311(2):86-91.

(183) Ilan Y, Shouval D, Galun E, Goldin E, Ligumsky M, Friedman G, et al. Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus. Scand J Gastroenterol 1996;31(4):415-416.

(184) Ilan Y, Galun E, Nagler A, Baruch Y, Livni N, Tur-Kaspa R. Sanctuary of hepatitis B virus in bone-marrow cells of patients undergoing liver transplantation. LIVER TRANSPLANT SURG 1996;2(3):206-210.

(185) Marcus H, David M, Canaan A, Kulova L, Lubin I, Segall H, et al. Human/mouse radiation chimera are capable of mounting a human primary humoral response. Blood 1995;86(1):398-406.

(186) von Weizsäcker F, Maeda E, Brown N, Poynard T, Galun E, Labeit S, et al. Heptitis B and C virus infection in HBsAg-negative alcoholics without i.v. drug abuse or previous blood transfusions. Int Hepatol Commun 1995;4(2):80-87.

(187) Abramov Y, Galun E, Granat M, Barak V, Abramov D, Plotkin V, et al. Postpartum systemic capillary leak syndrome: a possible etiology. Acta Obstet Gynecol Scand 1995;74(5):395-398.

(188) Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis LM, et al. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer 1995;75(10):2420-2426.

(189) Galun E, Burakova T, Ketzinel M, Lubin I, Shezen E, Kahana Y, et al. Hepatitis c virus viremia in scid→bnx mouse chimera. J Infect Dis 1995;172(1):25-30.

(190) Ilan Y, Shouval D, Galun E, Feder R, Adler R, Yatziv S. Correction of β-glucuronidase deficiency in mice by intrasplenic transplantation of isolated hepatocytes. Int Hepatol Commun 1995;3(2):97-104.

(191) Galun E, Ilan Y, Livni N, Ketzinel M, Nahor O, Pizov G, et al. Hepatitis B virus infection associated with hematopoietic tumors. Am J Pathol 1994;145(5):1001-1007.

(192) Schwartz E, Ilan Y, Galun E. Hepatitis E virus infection. Harefuah 1994;127(7-8):249-251.

(193) Schwartz E, Galun E. Prior hepatitis A virus infection enhances acute hepatitis E virus infection. Med Hypotheses 1994;42(3):198-202.

(194) BEN‐SASSON SA, FINESTONE A, MOSKOWITZ M, MARON R, WEINNER M, LEICHTER I, et al. Extended duration of vertical position might impair bone metabolism. Eur J Clin Invest 1994;24(6):421-425.

(195) Burstein R, Hourvitz A, Epstein Y, Dvir Z, Moran D, Altar J, et al. The relationship between short-term antibiotic treatments and fatigue in healthy individuals. Europ J Appl Physiol 1993;66(4):372-375.

(196) Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, et al. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J 1993;7(14):1407-1413.

(197) Liang TJ, Rustgi V, Galun E, Blum HE. HCV RNA in patients with chronic hepatitis C treated with interferon‐α. J Med Virol 1993;40(1):69-75.

(198) Han Y, Galun E. Glomerulonephritis associated with acute HAV infection. J Clin Gastroenterol 1992;15(1):85.

(199) Blum HE, Zhang Z-, Galun E, Von Weizsacker F, Garner B, Liang TJ, et al. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol 1992;66(2):1223-1227.

(200) Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D. Relapsing hepatitis: A review of 14 cases and literature survey. Medicine 1992;71(1):14-23.

(201) Galun E, Offensperger W-, Von Weizsacker F, Offensperger S, Wands JR, Blum HE. Human non-hepatocytes support hepadnaviral replication and virion production. J Gen Virol 1992;73(1):173-178.

(202) Galun E, Tur-Kaspa I, Assia E, Burstein R, Strauss N, Epstein Y, et al. Hyponatremia induced by exercise: a 24-hour endurance march study. Miner Electrolyte Metab 1991;17(5):315-320.

(203) Blum HE, Galun E, Weizsäcker FV, Wands JR. Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Lancet 1991;337(8751):1230.

(204) Blum HE, Galun E, Liang TJ, Von Weizsacker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991;65(4):1836-1842.

(205) Flugelman MY, Weisstub E, Galun E, Weiss AT, Fischer D, De-Nour AK, et al. Clinical, psychological and thallium stress studies in patients with chest pain and normal coronary arteries. Int J Cardiol 1991;33(3):401-408.

(206) Glikson M, Gil-Ad I, Galun E, Dresner R, Zilberman S, Halperin Y, et al. Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli. Acta Endocrinol 1991;125(4):366-371.

(207) Ilan Y, Hillman M, Oren R, Galun E, Shalit M. Undetectable caeruloplasmin values in a patient with autoimmune chronic active hepatitis. Gut 1991;32(5):549-550.

(208) Blum A, Rubinow A, Galun E. Predominance of renal involvement in male patients with systemic lupus erythematosus [2]. Clin Exp Rheumatol 1991;9(2):206-207.

(209) Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991;14(1):56-63.

(210) Galun E, Flugelman MY, Glickson M, Eliakim M. Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation. Chest 1991;99(4):1038-1040.

(211) Burstein R, Galun E. Exercise-induced hyponatremia - As rare as believed? Med Sci Sports Exerc 1990;22(6):879.

(212) Glikson M, Pollack A, Galun E, Dresner-Feigin R, Wolf D, Kaspa RT. Pentamidine-induced cardiotoxicity. Isr J Med Sci 1990;26(10):588-589.

(213) Burstein R, Galun E. Letter to the editor-in-chief. Med Sci Sports Exerc 1990;22(6):879.

(214) Burstein M, Galun E, Ben-Chetrit E. Idiopathic sclerosing peritonitis in a man. J Clin Gastroenterol 1990;12(6):698-701.

(215) Flugelman MY, Galun E, Ben-Chetrit E, Caraco J, Rubinow A. Brucellosis in patients with heart disease: When should endocarditis be diagnosed. Cardiology 1990;77(4):313-317.

(216) Galun E, Shouval D, Adler R, Shahaar M, Wilchek M, Hurwitz E, et al. The effect of anti‐α‐fetoprotein‐adriamycin conjugate on a human hepatoma. Hepatology 1990;11(4):578-584.

(217) Glikson M, Pollack A, Dresner-Feigin R, Galun E, Rubinow A. Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome. Chest 1990;98(3):759-761.

(218) Galun E, Rubinow A. Photocopier's papillitis. Lancet 1989;2(8668):929.

(219) Lapidoth T, Galun E. Hyperglycemia as a cause of chorea. Arch Intern Med 1989;149(8):1905.

(220) Glikson M, Galun E, Schlesinger M, Cohen D, Haskell L, Rubinow A, et al. Polyarteritis nodosa and familial Mediterranean fever: A report of 2 cases and review of the literature. J Rheumatol 1989;16(4):536-539.

(221) Galun E, Burstein R, Tur-Kaspa I, Assia E, Epstein Y. Prediction of physical performance through muscle enzymes activity. Europ J Appl Physiol 1988;57(5):597-600.

(222) Feigin RD, Glikson M, Gur H, Galun E, Younis JF, Beyth Y. Induction of ovulation causing recurrent bloody ascites in a woman with endometriosis. Am J Obstet Gynecol 1988;159(5):1161-1162.

(223) Shouval D, Anton M, Galun E. Erythropoietin-induced Polycythemia in Athymic Mice following Transplantation of a Human Renal Carcinoma Cell Line. Cancer Res 1988;48(12):3430-3434.

(224) Libson E, Fields S, Strauss S, Bloom RA, Okon E, Galun E, et al. Widespread Castleman disease: CT and US findings. Radiology 1988;166(3):753-755.

(225) Galun E, Oren R, Glikson M, Friedlander M, Heyman A. Phenazopyridine-induced hemolytic anemia in G-6-PD deficiency. Drug Intell Clin Pharm 1987;21(11):921-922.

(226) Galun E, Burstein R, Assia E, Tur-Kaspa I, Rosenblum J, Epstein Y. Changes of white blood cell count during prolonged exercise. Int J Sports Med 1987;8(4):253-255.

(227) Libson E, Bloom RA, Galun E, Polliack A. Granulocytic sarcoma (chloroma) of bone: The CT appearance. Comput Radiol 1986;10(4):175-178.

(228) Galun E, Ben-Yehuda A, Berlatzki J, Ben-Chetrit E, Gross DJ. Insulinoma complicating pregnancy: Case report and review of the literature. Am J Obstet Gynecol 1986;155(1):64-65.

(229) Galun E, Flugelman MY, Rachmilewitz D. Pyoderma Gangrenosum Complicating Ulcerative Colitis: Successful Treatment with Methylprednisolone Pulse Therapy and Dapsone. Am J Gastroenterol 1986;81(10):988-989.

(230) Shalit M, Flugelman MY, Harats N, Galun E, Ackerman Z, Kopolovic J, et al. Quinidine-Induced Vasculitis. Arch Intern Med 1985;145(11):2051-2052.

(231) Galun E, Braverman D, Ligumsky M. Primary mesothelioma of the peritoneum. Harefuah 1985;108(12):593-594+623.

(232) Slavin S, Or R, Weiss L, Steiner-Zalz D, Cividalli G, Brautbar C, et al. Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1. Adv Exp Med Biol 1985;186:813-818.

(233) Galun E, Epstein Y. Serum creatine kinase activity following a 120-km march. Clin Chim Acta 1984;143(3):281-283.

(234) Galun E, Ben-Chetrit E. Possible prevention of tick-borne relapsing fever in patients infected with Borrelia recurrentis. J Infect Dis 1984;150(4):617.